Tamoxifen therapy and hepatic steatosis

Neoplasma

Volumn 49, Issue 1, 2002, Pages 61-64

  Coskun, U ^a   Toruner F B ^a   Gunel N ^a  

^a GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

Hepatic steatosis; Lipid levels; Tamoxifen

Indexed keywords

TAMOXIFEN;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; DRUG EFFECT; FATTY LIVER; FEMALE; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY;

EID: 0036204302     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Effects of tamoxifen on plasma lipids and lipoprotein composition
2. Tamoxifen, serum lipoproteins and cardiovascular risk
3. Tamoxifen-induced transient multifocal hepatic fatty infiltration
4. Long-term effects of tamoxifen on blood lipid values in breast cancer
5. Tamoxifen for early breast cancer: An overview of the randomized trials
6. The beneficial effect of tamoxifen on serum lipoprotein-A levels: An additional anti-atherogenic property
7. A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor positive tumors
8. The effect of the antiestrogen tamoxifen on cardiovasculer risk factors in normal postmenopausal women
9. Tamoxifen-induced steatohepatitis
10. Severe hypertriglyceridemia caused by tamoxifen treatment after breast cancer surgery
11. Tamoxifen and hypertriglyceridemia
12. Ultrasound of liver and spleen
13. Prospects for antiestrogen chemoprevention of breast cancer
14. Effects of tamoxifen therapy on lipid and lipoprotein levels in postmenopausal patients with node negative breast cancer
15. Effects of tamoxifen on cardiovascular risk factors in postmenopausal women
16. Effects of tamoxifen on serum lipid and apolipoprotein levels in postmenopausal patients with breast cancer
17. Unrecognized hepatic steatosis and non-alcoholic steatohepatitis in adjuvant tamoxifen for breast cancer patients
18. Tamoxifen-induced steatohepatitis
19. Tamoxifen-associated steatohepatitis - Report of three cases
20. Tamoxifen and estrogen lower circulating lipoprotein (a) concentration in healthy postmenopausal women
21. Effects of tamoxifen on plasma lipids and lipoprotein in postmenopausal women with breast cancer
22. Prevention of breast cancer with tamoxifen: Preliminary findings from the Italian randomized trial among hysterectomised women
23. Administration of long-term tamoxifen therapy modifies the plasma lipoprotein-lipid concentration and lipid transfer protein activity in postmenopausal women with breast cancer